The Antibody‐Complement System and Properdin: A Review

P was originally conceived as a unique serum substance, which in the assumed absence of Ab, inactivated C and, in conjunction with C, participated in the killing of bacteria, the inactivation of viruses, and the hemolysis of abnormal red blood cells. More recent evidence has indicated, on the contrary, that Ab is an essential requirement for these reactions. In this revised orientation of the relationship of P and normal serum activities, the part played by P is uncertain and remains to be determined. There is no rigorous evidence at this time that P is involved in nonspecific resistance to infection or in neoplastic growth. The introduction of P as a serological entity nonetheless contributed a great deal to scientific advance by stimulating and revitalizing research efforts in many neglected areas, particularly those related to non‐specific resistance to infection.

[1]  C. Southam Are There Host Defenses Against Cancer , 1961 .

[2]  A. Laurell,et al.  Properdin Titers in Sera from Germfree Rats.∗ , 1960, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[3]  C. Hinz,et al.  The properdin system and immunity. XIV. The injection of human properdin into rabbits and the production of antibodies to properdin. , 1960, Journal of immunology.

[4]  K. Pondman,et al.  The Formation of Antibodies Against a Properdin Preparation. II , 1960, Vox sanguinis.

[5]  L. H. Muschel Bactericidal Activity of Normal Serum Against Bacterial Cultures. II. Activity Against Escherichia coli Strains , 1960, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6]  B. Benacerraf Influence of irradiation on resistance to infection. , 1960, Bacteriological reviews.

[7]  L. H. Muschel,et al.  The bactericidal action of normal serum and the properdin system. , 1960, Journal of immunology.

[8]  F. Rosen,et al.  Inactivation of endotoxin by a humoral component. VI. Two separate systems required for viable and killed Salmonella typhosa. , 1960, The Journal of clinical investigation.

[9]  C. P. Miller,et al.  The effect of irradiation on natural bactericidins of mice. , 1960, Journal of immunology.

[10]  J. G. Michael,et al.  Modification of Bactericidal Effects of Human Sera.∗ , 1959 .

[11]  M. Shilo Nonspecific Resistance to Infections , 1959 .

[12]  C. Southam,et al.  Studies of Properdin System in Human Cancer Cell Cultures.∗ , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  R. Wedgwood,et al.  The properdin system and immunity. X. Characterization of partially purified human properdin. , 1959, Journal of immunology.

[14]  L. H. Muschel,et al.  Neutralization of Bacteriophage by Normal Serum , 1959, Nature.

[15]  B. E. Sanders,et al.  Properdin: preparation from plasma fraction I of the Cohn method. , 1959, The Journal of biological chemistry.

[16]  J. Turk Immunological Activity of Precolostral Calf Serum , 1959, Nature.

[17]  L. Baron,et al.  Formation of bacterial protoplasts by serum components. , 1959, Journal of immunology.

[18]  J. Willers,et al.  An Improved Properdin Titration, Based on the Elimination of an Inhibitor , 1959, Vox sanguinis.

[19]  K. M. Cowan Interpretation of properdin levels determined by phage neutralization technique. , 1958, Science.

[20]  R. A. Nelson AN ALTERNATIVE MECHANISM FOR THE PROPERDIN SYSTEM , 1958, The Journal of experimental medicine.

[21]  R. Wedgwood,et al.  The nature and interactions of the properdin system. , 1958, Acta haematologica.

[22]  L. Levine,et al.  Studies on the inactivation of phage by the properdin system. II. Quantitative assay of phage-neutralizing activity. , 1958, Journal of immunology.

[23]  O. A. Ross Experimental studies of the in vivo relationships of the properdin system to resistance to infection. , 1958, The American journal of pathology.

[24]  A ROTTINO,et al.  A study of the serum properdin levels of patients with malignant tumors , 1958, Cancer.

[25]  C. Jenkin,et al.  A reaction between fresh serum and lipopolysaccharides of gram-negative bacteria. , 1958, British journal of experimental pathology.

[26]  L. Levine,et al.  Studies of the Inactivation of Phage by the Properdin System , 1958, Journal of immunology.

[27]  C. Southam,et al.  Serum Properdin Levels and Cancer Cell Homografts in Man.∗ , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[28]  R. Skarnes,et al.  Antimicrobial factors of normal tissues and fluids. , 1957, Bacteriological reviews.

[29]  Wardlaw Ac Observations on the Increase in Serum Bactericidal Activity in the Presence of Clinical Dextran , 1957 .

[30]  H. Green,et al.  THE ROLE OF A NATURAL ANTIBODY IN THE REJECTION OF MOUSE TUMOR CELLS BY THE CHICK EMBRYO , 1957, The Journal of experimental medicine.

[31]  C. Hinz,et al.  Preparation and properties of antihuman properdin rabbit serum. , 1957, Science.

[32]  E. Lowbury,et al.  Properdin and the defence of burns against infection , 1957, Journal of Hygiene.

[33]  J. Fine THE EFFECT OF PERIPHERAL VASCULAR COLLAPSE ON THE ANTIBACTERIAL DEFENSE MECHANISMS , 1956 .

[34]  O. A. Ross THE PROPERDIN SYSTEM IN RELATION TO FATAL BACTEREMIA FOLLOWING TOTAL‐BODY IRRADIATION OF LABORATORY ANIMALS , 1956 .

[35]  H. Feldman THE RELATIONSHIP OF TOXOPLASMA ANTIBODY ACTIVATOR TO THE SERUM‐PROPERDIN SYSTEM , 1956 .

[36]  D. Surgenor,et al.  PHAGOCYTOSIS‐PROMOTING FACTOR OF PLASMA AND SERUM , 1956 .

[37]  C. Hinz PROPERDIN LEVELS IN INFECTIOUS AND NONINFECTIOUS DISEASE , 1956 .

[38]  L. Pillemer THE NATURE OF THE PROPERDIN SYSTEM AND ITS INTERACTIONS WITH POLYSACCHARIDE COMPLEXES , 1956 .

[39]  Q. Myrvik SERUM BACTERICIDINS ACTIVE AGAINST GRAM‐POSITIVE BACTERIA , 1956 .

[40]  M. Heidelberger,et al.  CROSS-REACTIONS OF ANTITYPHOID AND ANTIPARATYPHOID B HORSE SERA WITH VARIOUS POLYSACCHARIDES , 1956, The Journal of experimental medicine.

[41]  M. Landy,et al.  INCREASED RESISTANCE TO INFECTION AND ACCOMPANYING ALTERATION IN PROPERDIN LEVELS FOLLOWING ADMINISTRATION OF BACTERIAL LIPOPOLYSACCHARIDES , 1956, The Journal of experimental medicine.

[42]  Benjamin Blattberg,et al.  Increase in Bactericidal Activity as a Result of Injection of Zymosan , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[43]  R. Dubos,et al.  REVERSIBLE CHANGES IN THE SUSCEPTIBILITY OF MICE TO BACTERIAL INFECTIONS , 1956, The Journal of experimental medicine.

[44]  A. Wardlaw,et al.  THE PROPERDIN SYSTEM AND IMMUNITY , 1956, The Journal of experimental medicine.

[45]  A. Wardlaw,et al.  The properdin system and immunity. V. The bactericidal activity of the properdin system. , 1956 .

[46]  W. S. Jordan,et al.  The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria. , 1956, The Journal of clinical investigation.

[47]  H. Isliker,et al.  The Properdin System , 1956, Lancet.

[48]  A. Wardlaw,et al.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. , 1954, Science.

[49]  A. M. Pappenheimer,et al.  A quantitative study of the diphtheria toxin-antitoxin reaction in the sera of various species including man. , 1949, Journal of immunology.

[50]  P. B. Cowles Experimental Immunochemistry , 1948, The Yale Journal of Biology and Medicine.

[51]  F. Rosen,et al.  INACTIVATION OF E N D O T O X I N BY A HUMORAL COMPONENT II I . ROLE OF DIVALENT CATION AND A DIALYZ~LV. Com'ONV~vr BY FRED , 2003 .

[52]  R. A. Day,et al.  Immunochemical approaches to problems in microbiology , 1961 .

[53]  A. G. Osler Functions of the Complement System1 , 1961 .

[54]  A. L. Bloomfield BACTERIAL AND MYCOTIC INFECTIONS OF MAN , 1959 .

[55]  A. Wardlaw Observations on the increase in serum bactericidal activity in the presence of clinical dextran. , 1957, British journal of experimental pathology.